A functional magnetic resonance imaging study of the effects of low frequency right prefrontal transcranial magnetic stimulation in depression
- PMID: 17873682
- DOI: 10.1097/jcp.0b013e318151521c
A functional magnetic resonance imaging study of the effects of low frequency right prefrontal transcranial magnetic stimulation in depression
Abstract
The study aimed to explore the biological effects of low-frequency repetitive transcranial magnetic stimulation (LFR-TMS) treatment applied to the right prefrontal cortex, comparing this with the effects of high-frequency left-sided (HFL-TMS) in patients with treatment-resistant depression. Twenty-six patients with treatment-resistant depression were randomized to receive either daily LFR-TMS or HFL-TMS treatment for 3 weeks and underwent functional magnetic resonance imaging during a planning task before and after treatment. Patients responded clinically to both forms of treatment with no difference in the degree of response (F1,24 = 0.65;P > 0.05). Low-frequency repetitive transcranial magnetic stimulation resulted in no overall change in task-related activation. However, responders to LFR-TMS demonstrated a bilateral decrease in activity in middle frontal gyrus. In contrast, HFL-TMS produced an increase in activation in left precuneus with responders showing increased activation in several additional regions. Response to LFR-TMS is associated with a bilateral reduction in frontal activation that does not seem to be a nonspecific effect of treatment and differs from the response to HFL-TMS.
Similar articles
-
Transcranial magnetic stimulation in the treatment of depression: a double-blind, placebo-controlled trial.Arch Gen Psychiatry. 2003 Oct;60(10):1002-8. doi: 10.1001/archpsyc.60.9.1002. Arch Gen Psychiatry. 2003. PMID: 14557145 Clinical Trial.
-
A study of the effectiveness of high-frequency left prefrontal cortex transcranial magnetic stimulation in major depression in patients who have not responded to right-sided stimulation.Psychiatry Res. 2009 Aug 30;169(1):12-5. doi: 10.1016/j.psychres.2008.06.017. Epub 2009 Jul 23. Psychiatry Res. 2009. PMID: 19631391
-
A randomized trial of the anti-depressant effects of low- and high-frequency transcranial magnetic stimulation in treatment-resistant depression.Depress Anxiety. 2009;26(3):229-34. doi: 10.1002/da.20454. Depress Anxiety. 2009. PMID: 19105212 Clinical Trial.
-
Repetitive transcranial magnetic stimulation of the prefrontal cortex in depression.Exp Neurol. 2009 Sep;219(1):2-13. doi: 10.1016/j.expneurol.2009.04.020. Epub 2009 May 4. Exp Neurol. 2009. PMID: 19409383 Review.
-
[Transcranial magnetic stimulation in depression].Encephale. 2002 Mar-Apr;28(2):169-75. Encephale. 2002. PMID: 11972144 Review. French.
Cited by
-
Reduced executive and reward connectivity is associated with smoking cessation response to repetitive transcranial magnetic stimulation: A double-blind, randomized, sham-controlled trial.Brain Imaging Behav. 2024 Feb;18(1):207-219. doi: 10.1007/s11682-023-00820-3. Epub 2023 Nov 23. Brain Imaging Behav. 2024. PMID: 37996557 Free PMC article. Clinical Trial.
-
Associations between frontal lobe activity and depressive symptoms in patients with major depressive disorder receiving rTMS treatment: a near-infrared spectroscopy study.Front Psychiatry. 2023 Aug 16;14:1235713. doi: 10.3389/fpsyt.2023.1235713. eCollection 2023. Front Psychiatry. 2023. PMID: 37654993 Free PMC article.
-
Functional Activity in the Effect of Transcranial Magnetic Stimulation Therapy for Patients with Depression: A Meta-Analysis.J Pers Med. 2023 Feb 24;13(3):405. doi: 10.3390/jpm13030405. J Pers Med. 2023. PMID: 36983590 Free PMC article. Review.
-
Assessing the mechanisms of brain plasticity by transcranial magnetic stimulation.Neuropsychopharmacology. 2023 Jan;48(1):191-208. doi: 10.1038/s41386-022-01453-8. Epub 2022 Oct 5. Neuropsychopharmacology. 2023. PMID: 36198876 Free PMC article. Review.
-
A preliminary study on predictors of treatment response to repetitive transcranial magnetic stimulation in patients with treatment-resistant depression in Japan.Neuropsychopharmacol Rep. 2022 Dec;42(4):478-484. doi: 10.1002/npr2.12290. Epub 2022 Aug 30. Neuropsychopharmacol Rep. 2022. PMID: 36039823 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources